Administration of Afala in urological practice


Cite item

Full Text

Abstract

Our studies of afala in patients with prostatic adenoma demonstrate that afala reduces irritative disorders of urination. Effect of this drug is seen in 98.3% patients during 4 weeks of its use. In longer intake the effect becomes stronger. The dose of 6 tablets a day significantly improves life quality. Three times a day dose is more effective in elimination of nicturia, enhances urine flow rate. Thus, choice of afala dose depends on the symptoms. Afala is indicated for prophylaxis in patients with initial stage of prostatic adenoma and as an alternative to expectation policy.

References

  1. Catalona W. J., Smith D. S., Ratliff T. L. et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991; 324 (17): 1156-1161.
  2. Takayama T. K., Vessella R. L., Lange P. H. Never applications of serum prostate-specific antigen in the management of prostate cancer. Semin. Oncol. 1994; 21 (5): 542-553.
  3. Пушкарь Д. Ю., Раснер П. И. Медикаментозная профилактика рака предстательной железы. Онкоурология 2008; 2: 73-77.
  4. Яковец Е. А. Роль регулятора активности инсулиноподобного фактора роста в комплексной терапии больных ДГП. В кн.: Современные вопросы урологии, андрологии, репродуктивной медицины: Материалы VII Межрегиональной конф. Новосибирск; 2008. 348-351.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies